• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RhoA-ROCK信号通路在良性前列腺增生中的作用:综述

The role of RhoA-ROCK signaling in benign prostatic hyperplasia: a review.

作者信息

Shan Shidong, Su Min

机构信息

Department of Renal Transplantation, Guangdong Provincial People' Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.

Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China.

出版信息

Hum Cell. 2025 Feb 1;38(2):48. doi: 10.1007/s13577-025-01179-x.

DOI:10.1007/s13577-025-01179-x
PMID:39891836
Abstract

Benign prostatic hyperplasia (BPH) is a common urological disease in middle-aged and elderly men. The main pathological mechanisms of BPH include static factors that increase prostate volume and dynamic factors that increase prostate tension. The RhoA/ROCK signaling pathway is a classical pathway that regulates cell contraction, migration, and growth. In this review, we summarize the potential role of RhoA/ROCK signaling in the development of BPH. The RhoA/ROCK signaling pathway can enhance the contraction of prostate smooth muscle through the Ca sensitization pathway and increase passive tension in the prostate through tissue fibrosis. Additionally, RhoA/ROCK signaling promotes cell proliferation by regulating cell division and may influence apoptosis by affecting the actin cytoskeleton. Furthermore, risk factors, such as inflammation, metabolic syndrome, and hormonal changes, can upregulate RhoA/ROCK signaling, which in turn promotes these risk factors, eventually leading to the development of BPH. Given the role of RhoA/ROCK signaling in regulating multiple pathogenic factors of BPH, this pathway represents a promising molecular target for BPH treatment and warrants further study.

摘要

良性前列腺增生(BPH)是中老年男性常见的泌尿系统疾病。BPH的主要病理机制包括增加前列腺体积的静态因素和增加前列腺张力的动态因素。RhoA/ROCK信号通路是调节细胞收缩、迁移和生长的经典通路。在本综述中,我们总结了RhoA/ROCK信号在BPH发生发展中的潜在作用。RhoA/ROCK信号通路可通过钙敏化途径增强前列腺平滑肌的收缩,并通过组织纤维化增加前列腺的被动张力。此外,RhoA/ROCK信号通过调节细胞分裂促进细胞增殖,并可能通过影响肌动蛋白细胞骨架影响细胞凋亡。此外,炎症、代谢综合征和激素变化等危险因素可上调RhoA/ROCK信号,进而促进这些危险因素,最终导致BPH的发生。鉴于RhoA/ROCK信号在调节BPH多种致病因素中的作用,该通路是BPH治疗有前景的分子靶点,值得进一步研究。

相似文献

1
The role of RhoA-ROCK signaling in benign prostatic hyperplasia: a review.RhoA-ROCK信号通路在良性前列腺增生中的作用:综述
Hum Cell. 2025 Feb 1;38(2):48. doi: 10.1007/s13577-025-01179-x.
2
Mechanism of RhoA regulating benign prostatic hyperplasia: RhoA-ROCK-β-catenin signaling axis and static & dynamic dual roles.RhoA 调节良性前列腺增生的机制:RhoA-ROCK-β-catenin 信号轴及静态和动态双重作用。
Mol Med. 2023 Oct 20;29(1):139. doi: 10.1186/s10020-023-00734-2.
3
Sex steroid receptors in male human bladder: expression and biological function.男性膀胱中的性类固醇受体:表达和生物学功能。
J Sex Med. 2010 Aug;7(8):2698-713. doi: 10.1111/j.1743-6109.2010.01811.x. Epub 2010 Apr 20.
4
The vitamin D receptor agonist elocalcitol inhibits IL-8-dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF-kappaB pathways.维生素D受体激动剂依洛膦酸通过靶向RhoA/Rho激酶和NF-κB途径抑制白细胞介素-8依赖性良性前列腺增生基质细胞增殖和炎症反应。
Prostate. 2009 Apr 1;69(5):480-93. doi: 10.1002/pros.20896.
5
Mechanical stretch upregulates proteins involved in Ca2+ sensitization in urinary bladder smooth muscle hypertrophy.机械拉伸上调参与膀胱平滑肌肥大中 Ca2+ 敏化的蛋白质。
Am J Physiol Cell Physiol. 2014 Sep 15;307(6):C542-53. doi: 10.1152/ajpcell.00033.2014. Epub 2014 Jul 16.
6
Y-27632 targeting ROCK1&2 modulates cell growth, fibrosis and epithelial-mesenchymal transition in hyperplastic prostate by inhibiting β-catenin pathway.靶向 ROCK1&2 的 Y-27632 通过抑制β-catenin 通路调节前列腺增生中的细胞生长、纤维化和上皮间质转化。
Mol Biomed. 2024 Oct 26;5(1):52. doi: 10.1186/s43556-024-00216-9.
7
RhoA/Rho kinase-mediated Ca2+ sensitization in the contraction of human prostate.RhoA/ Rho激酶介导的人前列腺收缩中的Ca2+ 增敏作用
Neurourol Urodyn. 2007;26(4):547-551. doi: 10.1002/nau.20365.
8
RhoA/ROCK signaling regulates smooth muscle phenotypic modulation and vascular remodeling via the JNK pathway and vimentin cytoskeleton.RhoA/ROCK 信号通路通过 JNK 通路和波形蛋白细胞骨架调节平滑肌表型调节和血管重塑。
Pharmacol Res. 2018 Jul;133:201-212. doi: 10.1016/j.phrs.2018.05.011. Epub 2018 May 20.
9
Silencing of URG11 expression inhibits the proliferation and epithelial‑mesenchymal transition in benign prostatic hyperplasia cells via the RhoA/ROCK1 pathway.抑制 URG11 表达通过 RhoA/ROCK1 通路抑制良性前列腺增生细胞的增殖和上皮-间充质转化。
Mol Med Rep. 2018 Jul;18(1):391-398. doi: 10.3892/mmr.2018.8993. Epub 2018 May 8.
10
LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.长链非编码 RNA-SMILR 通过靶向 miR-141 调节 RhoA/ROCK 信号通路,从而调节肺动脉高压中的血管重构。
Am J Physiol Heart Circ Physiol. 2020 Aug 1;319(2):H377-H391. doi: 10.1152/ajpheart.00717.2019. Epub 2020 Jun 19.

本文引用的文献

1
Y-27632 targeting ROCK1&2 modulates cell growth, fibrosis and epithelial-mesenchymal transition in hyperplastic prostate by inhibiting β-catenin pathway.靶向 ROCK1&2 的 Y-27632 通过抑制β-catenin 通路调节前列腺增生中的细胞生长、纤维化和上皮间质转化。
Mol Biomed. 2024 Oct 26;5(1):52. doi: 10.1186/s43556-024-00216-9.
2
Ocular effects of Rho kinase (ROCK) inhibition: a systematic review.Rho激酶(ROCK)抑制的眼部效应:一项系统评价。
Eye (Lond). 2024 Dec;38(18):3418-3428. doi: 10.1038/s41433-024-03342-4. Epub 2024 Sep 16.
3
The synthesis and bioactivities of ROCK2 inhibitors with 1,2-dithiolan-3-yl motif.
具有1,2 - 二硫杂环戊烷 - 3 - 基 motif的ROCK2抑制剂的合成与生物活性
RSC Med Chem. 2024 Aug 1;15(10):3576-96. doi: 10.1039/d4md00438h.
4
Novel Small-Molecule ROCK2 Inhibitor GNS-3595 Attenuates Pulmonary Fibrosis in Preclinical Studies.新型小分子 ROCK2 抑制剂 GNS-3595 可减轻临床前研究中的肺纤维化。
Am J Respir Cell Mol Biol. 2024 Oct;71(4):430-441. doi: 10.1165/rcmb.2023-0401OC.
5
The novel ROCK2 selective inhibitor NRL-1049 preserves the blood-brain barrier after acute injury.新型 ROCK2 选择性抑制剂 NRL-1049 可保护急性损伤后的血脑屏障。
J Cereb Blood Flow Metab. 2024 Nov;44(11):1238-1252. doi: 10.1177/0271678X241238845. Epub 2024 Jun 4.
6
The human microbiome and benign prostatic hyperplasia: Current understandings and clinical implications.人类微生物组与良性前列腺增生:当前认识和临床意义。
Microbiol Res. 2024 Apr;281:127596. doi: 10.1016/j.micres.2023.127596. Epub 2024 Jan 3.
7
Patterning of the cell cortex by Rho GTPases.Rho GTPases 对细胞皮层的模式化作用。
Nat Rev Mol Cell Biol. 2024 Apr;25(4):290-308. doi: 10.1038/s41580-023-00682-z. Epub 2024 Jan 3.
8
Selectivity matters: selective ROCK2 inhibitor ameliorates established liver fibrosis via targeting inflammation, fibrosis, and metabolism.选择性很重要:选择性 ROCK2 抑制剂通过靶向炎症、纤维化和代谢改善已建立的肝纤维化。
Commun Biol. 2023 Nov 18;6(1):1176. doi: 10.1038/s42003-023-05552-0.
9
Design, Synthesis, and Biological Evaluation of an Orally Bioavailable, Potent, and Selective ROCK2 Inhibitor for Psoriasis Treatment.设计、合成及具有口服生物利用度的、高效的和选择性的 ROCK2 抑制剂用于治疗银屑病的生物学评价。
J Med Chem. 2023 Nov 23;66(22):15205-15229. doi: 10.1021/acs.jmedchem.3c01297. Epub 2023 Nov 9.
10
Mechanism of RhoA regulating benign prostatic hyperplasia: RhoA-ROCK-β-catenin signaling axis and static & dynamic dual roles.RhoA 调节良性前列腺增生的机制:RhoA-ROCK-β-catenin 信号轴及静态和动态双重作用。
Mol Med. 2023 Oct 20;29(1):139. doi: 10.1186/s10020-023-00734-2.